Blue Water Vaccines amends 8-K to disclose $17.2M net IPO proceeds

Onconetix, Inc.

Net proceeds from IPO approximately $17.2M after underwriting discount and expenses.
IPO of 2,222,222 shares at $9.00 per share closed Feb 23, 2022.
James Sapirstein appointed to board, replacing John Rice (resigned).
All outstanding preferred shares converted into 5,626,365 common shares at closing.
Representative's warrants issued for 111,111 shares at $10.35 exercise price.

item 1.01 item 1.02 item 3.03 item 5.03 item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

James Sapirstein

member of the Board

ONCO · Onconetix, Inc.

Effective: 2022-02-23
Filed: March 4, 2022, 6:59 PM ET

Effective as of February 23, 2022, the Board appointed James Sapirstein to serve as a member of the Board.

Departed

John Rice

member of the Board of Directors

ONCO · Onconetix, Inc.

Effective: 2022-02-23
Successor: James Sapirstein
Filed: March 4, 2022, 6:59 PM ET

Effective as of February 23, 2022, John Rice resigned as a member of the Board of Directors (the “Board”) of Blue Water Vaccines Inc.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

James Sapirstein was appointed as member of the Board at Onconetix, Inc..

Action: appointed
Role: member of the Board

Exact text from the filing

Effective as of February 23, 2022, the Board appointed James Sapirstein to serve as a member of the Board.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

John Rice resigned as member of the Board of Directors at Onconetix, Inc..

Action: resigned
Role: member of the Board of Directors

Exact text from the filing

Effective as of February 23, 2022, John Rice resigned as a member of the Board of Directors (the “Board”) of Blue Water Vaccines Inc.

View on SEC.gov

Onconetix, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-22-010779

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.